Andrew J. Cutler, MD | Psychiatrist.com

Article

Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories

June 11, 2015

Reducing functional impairment in patients with major depressive disorder is critical for optimizing treatment outcomes and achieving long-term wellness. In this post hoc analysis, improvement in functional impairment in...

William M. Greenberg, Andrew J. Cutler, Adam Ruth, et al

Original Research

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

August 15, 2013

Madhukar H. Trivedi, Ashwin A. Patkar, Andrew J. Cutler, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

April 15, 2011

Arif Khan, Heidi Whalen, Carol R. Reed, et al

Original Research

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

April 7, 2009

David Feifel, Stuart A. Montgomery, Martin Brecher, et al

Original Research

Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

March 15, 2005

Terence A. Ketter, Paul E. Keck, Jr., Amir H. Kalali, et al

« 1 2